Drug Shortage Report for TEVA-RABEPRAZOLE EC

Last updated on 2017-10-11 History
Report ID 3133
Drug Identification Number 02296640
Brand name TEVA-RABEPRAZOLE EC
Common or Proper name RABEPRAZOLE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 20MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-17
Estimated end date 2017-11-30
Actual end date 2017-10-10
Shortage status Resolved
Updated date 2017-10-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2017-10-11 English Compare
v7 2017-10-10 French Compare
v6 2017-10-10 English Compare
v5 2017-09-05 French Compare
v4 2017-09-05 English Compare
v3 2017-03-18 English Compare
v2 2017-03-17 French Compare
v1 2017-03-17 English Compare